Correlation Between NYSE Composite and Zomedica Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both NYSE Composite and Zomedica Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NYSE Composite and Zomedica Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NYSE Composite and Zomedica Pharmaceuticals Corp, you can compare the effects of market volatilities on NYSE Composite and Zomedica Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NYSE Composite with a short position of Zomedica Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of NYSE Composite and Zomedica Pharmaceuticals.
Diversification Opportunities for NYSE Composite and Zomedica Pharmaceuticals
0.05 | Correlation Coefficient |
Significant diversification
The 3 months correlation between NYSE and Zomedica is 0.05. Overlapping area represents the amount of risk that can be diversified away by holding NYSE Composite and Zomedica Pharmaceuticals Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zomedica Pharmaceuticals and NYSE Composite is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NYSE Composite are associated (or correlated) with Zomedica Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zomedica Pharmaceuticals has no effect on the direction of NYSE Composite i.e., NYSE Composite and Zomedica Pharmaceuticals go up and down completely randomly.
Pair Corralation between NYSE Composite and Zomedica Pharmaceuticals
Assuming the 90 days trading horizon NYSE Composite is expected to generate 0.16 times more return on investment than Zomedica Pharmaceuticals. However, NYSE Composite is 6.3 times less risky than Zomedica Pharmaceuticals. It trades about 0.08 of its potential returns per unit of risk. Zomedica Pharmaceuticals Corp is currently generating about 0.01 per unit of risk. If you would invest 1,521,826 in NYSE Composite on September 15, 2024 and sell it today you would earn a total of 451,111 from holding NYSE Composite or generate 29.64% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
NYSE Composite vs. Zomedica Pharmaceuticals Corp
Performance |
| Timeline |
NYSE Composite and Zomedica Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
NYSE Composite
Pair trading matchups for NYSE Composite
Zomedica Pharmaceuticals Corp
Pair trading matchups for Zomedica Pharmaceuticals
Pair Trading with NYSE Composite and Zomedica Pharmaceuticals
The main advantage of trading using opposite NYSE Composite and Zomedica Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NYSE Composite position performs unexpectedly, Zomedica Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zomedica Pharmaceuticals will offset losses from the drop in Zomedica Pharmaceuticals' long position.| NYSE Composite vs. FARO Technologies | NYSE Composite vs. Apogee Therapeutics, Common | NYSE Composite vs. Genfit | NYSE Composite vs. Mind Medicine |
| Zomedica Pharmaceuticals vs. Tilray Inc | Zomedica Pharmaceuticals vs. Aurora Cannabis | Zomedica Pharmaceuticals vs. Canopy Growth Corp | Zomedica Pharmaceuticals vs. OrganiGram Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |